(Q38338162)

English

Polyadenylated RNA sequences from vaccinia virus-infected cells selectively inhibit translation in a cell-free system: Structural properties and mechanism of inhibition

scientific article published on December 1, 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Polyadenylated RNA sequences from vaccinia virus-infected cells selectively inhibit translation in a cell-free system: structural properties and mechanism of inhibition (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Polyadenylated RNA sequences from vaccinia virus-infected cells selectively inhibit translation in a cell-free system: Structural properties and mechanism of inhibition (English)

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

author name string

M. J. Su

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700540

2 November 2022

R. Bablanian

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700540

2 November 2022

language of work or name

0 references

publication date

1 December 1990

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:004268229090135E?httpAccept=text/xml

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

https://api.elsevier.com/content/article/PII:004268229090135E?httpAccept=text/plain

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

179

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

679-693

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Studies on the Mechanisms of Vaccinia Virus Cytopathic Effects: I. Inhibition of Protein Synthesis in Infected Cells is Associated with Virus-induced RNA Synthesis

3

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Inhibition of protein synthesis by vaccinia virus. III. The effect of ultraviolet-irradiated virus on the inhibition of protein synthesis

4

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Inhibition of protein synthesis by vaccinia virus. IV. The role of low-molecular-weight viral RNA in the inhibition of protein synthesis

5

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Characterization of vaccinia virus transcripts involved in selective inhibition of host protein synthesis

7

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Selective inhibition of protein synthesis by synthetic and vaccinia virus-core synthesized poly(riboadenylic acids).

8

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

MESSENGER RNA IN CELLS INFECTED WITH VACCINIA VIRUS

9

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Poly(A) polymerase from vaccinia virus-infected cells. II. Product and primer characterization.

11

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Discriminatory inhibition of protein synthesis in cell-free systems by vaccinia virus transcripts

13

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis

14

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Analysis of C14-labeled proteins by disc electrophoresis

15

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Abortive transcription products of vaccinia virus are guanylylated, methylated, and polyadenylylated

16

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

The poly(A)-binding protein facilitates in vitro translation of poly(A)-rich mRNA

17

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Cellular differences in the molecular mechanisms of vaccinia virus host range restriction

18

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Possible Involvement of poly(A) in protein synthesks

19

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

The purification fo four strains of poxvirus

20

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Ribonucleic acid synthesis in vaccinia virus. I. The mechanism of synthesis and release of RNA in vaccinia cores

21

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

23

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Inhibition of translation in L-cell lysates by free polyadenylic acid: differences in sensitivity among different mRNAs and possible involvement of an initiation factor

24

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

The use of single-stranded DNA and RNase H to promote quantitative 'hybrid arrest of translation' of mRNA/DNA hybrids in reticulocyte lysate cell-free translations

26

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Poly (A) sequences of vaccinia virus messenger RNA: nature, mode of addition and function during translation in vitra and in vivo

28

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Hybridization and sedimentation studies on “early” and “late” vaccinia messenger RNA

29

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

An efficient mRNA-dependent translation system from reticulocyte lysates

31

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency.

32

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Inhibition of host protein synthesis by vaccinia virus: fate of cell mRNA and synthesis of small poly (A)-rich polyribonucleotides in the presence of actinomycin D

33

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F

34

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

The poly(A) binding protein is required for poly(A) shortening and 60S ribosomal subunit-dependent translation initiation

35

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Initiation of mammalian protein synthesis: the importance of ribosome and initiation factor quality for the efficiency of in vitro systems

36

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Inhibition of protein synthesis by vaccinia virus I. Characterization of an inhibited cell-free protein-synthesizing system from infected Cells

37

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Capped mRNAs with Reduced Secondary Structure Can Function in Extracts from Poliovirus-Infected Cells

39

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Initiation of mammalian protein synthesis. II. The assembly of the initiation complex with purified initiation factors

40

1 reference

10.1016/0042-6822(90)90135-E

https://api.crossref.org/works/10.1016/0042-6822(90)90135-E

2 November 2022

Identifiers

10.1016/0042-6822(90)90135-E

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38338162&oldid=1802609120"